The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Microfluidic technologies and devices for lipid nanoparticle-based RNA delivery
Open accessAbstract
In 2021, mRNA vaccines against COVID-19 were approved by the Food and Drug Administration. mRNA vaccines are important for preventing severe COVID-19 and returning to normal life. The development of RNA-delivery technology, including mRNA vaccines, has been investigated worldwide for ~30 years. Lipid nanoparticles (LNPs) are a breakthrough technology that stably delivers RNA to target organs, and RNA-loaded LNP-based nanomedicines have been studied for the development of vaccines and nanomedicines for RNA-, gene-, and cell-based therapies. Recently, microfluidic devices and technologies have attracted attention for the production of LNPs, particularly RNA-loaded LNPs. Microfluidics provides many advantages for RNA-loaded LNP production, including precise LNP size controllability, high reproducibility, high-throughput optimization of LNP formulation, and continuous LNP-production processes. In this review, we summarize microfluidic-based RNA-loaded LNP production and its applications in RNA-based therapy and genome editing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mRNA vaccines — a new era in vaccinology
Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.243 · Cited by 4,667
Lipid nanoparticles for mRNA delivery
Hou, X., Zaks, T., Langer, R., & Dong, Y. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00358-0 · Cited by 4,076
Chaotic Mixer for Microchannels
Stroock, A. D., Dertinger, S. K. W., Ajdari, A., Mezić, I., Stone, H. A., & Whitesides, G. M. (2002) · Science · doi:10.1126/science.1066238 · Cited by 3,435 · cited 1×
“[57] described the concept of a chaotic mixer device in 2002, with this device subsequently widely used in the microfluidics field.”
Non-viral vectors for gene-based therapy
Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
Lopez Bernal, J., Andrews, N., Gower, C., Gallagher, E., Simmons, R., Thelwall, S., Stowe, J., Tessier, E., Groves, N., Dabrera, G., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2108891 · Cited by 2,889
Cheng, Q., Wei, T., Farbiak, L., Johnson, L. T., Dilliard, S. A., & Siegwart, D. J. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-0669-6 · Cited by 2,383
SARS-CoV-2 vaccines in development
Krammer, F. (2020) · Nature · doi:10.1038/s41586-020-2798-3 · Cited by 2,098
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
Akinc, A., Maier, M. A., Manoharan, M., Fitzgerald, K., Jayaraman, M., Barros, S., Ansell, S., Du, X., Hope, M. J., Madden, T. D., et al. (2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0591-y · Cited by 1,636
Emerging Droplet Microfluidics
Shang, L., Cheng, Y., & Zhao, Y. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00848 · Cited by 1,584
mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability
Schoenmaker, L., Witzigmann, D., Kulkarni, J. A., Verbeke, R., Kersten, G., Jiskoot, W., & Crommelin, D. J. A. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120586 · Cited by 1,566
Wearable sensors: modalities, challenges, and prospects
Heikenfeld, J., Jajack, A., Rogers, J., Gutruf, P., Tian, L., Pan, T., Li, R., Khine, M., Kim, J., Wang, J., et al. (2018) · Lab on a Chip · doi:10.1039/c7lc00914c · Cited by 1,434
Optimization of lipid nanoparticles for intramuscular administration of mRNA vaccines
Hassett, K. J., Benenato, K. E., Jacquinet, E., Lee, A., Woods, A., Yuzhakov, O., Himansu, S., Deterling, J., Geilich, B. M., Ketova, T., et al. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.01.013 · Cited by 927
Modified mRNA vaccines protect against zika virus infection
Richner, J. M., Himansu, S., Dowd, K. A., Butler, S. L., Salazar, V., Fox, J. M., Julander, J. G., Tang, W. W., Shresta, S., Pierson, T. C., et al. (2017) · Cell · doi:10.1016/j.cell.2017.02.017 · Cited by 909
Finn, J. D., Smith, A. R., Patel, M. C., Shaw, L., Youniss, M. R., van Heteren, J., Dirstine, T., Ciullo, C., Lescarbeau, R., Seitzer, J., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.02.014 · Cited by 878
Yin, H., Song, C.-Q., Dorkin, J. R., Zhu, L. J., Li, Y., Wu, Q., Park, A., Yang, J., Suresh, S., Bizhanova, A., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3471 · Cited by 876
Sabnis, S., Kumarasinghe, E. S., Salerno, T., Mihai, C., Ketova, T., Senn, J. J., Lynn, A., Bulychev, A., McFadyen, I., Chan, J., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.03.010 · Cited by 820 · cited 1×
“(225–250 g), Naive cynomolgus monkeys (2–4 years old, 2–6 kg) [82]”
Kauffman, K. J., Dorkin, J. R., Yang, J. H., Heartlein, M. W., DeRosa, F., Mir, F. F., Fenton, O. S., & Anderson, D. G. (2015) · Nano Letters · doi:10.1021/acs.nanolett.5b02497 · Cited by 796
Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy
Sridhar, S., Luedtke, A., Langevin, E., Zhu, M., Bonaparte, M., Machabert, T., Savarino, S., Zambrano, B., Moureau, A., Khromava, A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1800820 · Cited by 783
Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA
Belliveau, N. M., Huft, J., Lin, P. J., Chen, S., Leung, A. K., Leaver, T. J., Wild, A. W., Lee, J. B., Taylor, R. J., Tam, Y. K., et al. (2012) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2012.28 · Cited by 685 · cited 2×
“1 – > 95 – VII factor in mouse liver [37]”
Kulkarni, J. A., Darjuan, M. M., Mercer, J. E., Chen, S., van der Meel, R., Thewalt, J. L., Tam, Y. Y. C., & Cullis, P. R. (2018) · ACS Nano · doi:10.1021/acsnano.8b01516 · Cited by 663
Bahl, K., Senn, J. J., Yuzhakov, O., Bulychev, A., Brito, L. A., Hassett, K. J., Laska, M. E., Smith, M., Almarsson, Ö., Thompson, J., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.03.035 · Cited by 642
Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering
Billingsley, M. M., Singh, N., Ravikumar, P., Zhang, R., June, C. H., & Mitchell, M. J. (2020) · Nano Letters · doi:10.1021/acs.nanolett.9b04246 · Cited by 636
CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy
Rosenblum, D., Gutkin, A., Kedmi, R., Ramishetti, S., Veiga, N., Jacobi, A. M., Schubert, M. S., Friedmann-Morvinski, D., Cohen, Z. R., Behlke, M. A., et al. (2020) · Science Advances · doi:10.1126/sciadv.abc9450 · Cited by 614
Patel, S., Ashwanikumar, N., Robinson, E., Xia, Y., Mihai, C., Griffith, J. P., Hou, S., Esposito, A. A., Ketova, T., Welsher, K., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14527-2 · Cited by 601
Miller, J. B., Zhang, S., Kos, P., Xiong, H., Zhou, K., Perelman, S. S., Zhu, H., & Siegwart, D. J. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201610209 · Cited by 540
Controlled Vesicle Self-Assembly in Microfluidic Channels with Hydrodynamic Focusing
Jahn, A., Vreeland, W. N., Gaitan, M., & Locascio, L. E. (2004) · Journal of the American Chemical Society · doi:10.1021/ja0318030 · Cited by 537
Paper-Based Microfluidic Devices: Emerging Themes and Applications
Yang, Y., Noviana, E., Nguyen, M. P., Geiss, B. J., Dandy, D. S., & Henry, C. S. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.6b04581 · Cited by 501
Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing
Yin, H., Song, C.-Q., Suresh, S., Wu, Q., Walsh, S., Rhym, L. H., Mintzer, E., Bolukbasi, M. F., Zhu, L. J., Kauffman, K., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.4005 · Cited by 499
Microfluidic Mixing and the Formation of Nanoscale Lipid Vesicles
Jahn, A., Stavis, S. M., Hong, J. S., Vreeland, W. N., DeVoe, D. L., & Gaitan, M. (2010) · ACS Nano · doi:10.1021/nn901676x · Cited by 432
Chen, D., Love, K. T., Chen, Y., Eltoukhy, A. A., Kastrup, C., Sahay, G., Jeon, A., Dong, Y., Whitehead, K. A., & Anderson, D. G. (2012) · Journal of the American Chemical Society · doi:10.1021/ja301621z · Cited by 424
Sebastiani, F., Yanez Arteta, M., Lerche, M., Porcar, L., Lang, C., Bragg, R. A., Elmore, C. S., Krishnamurthy, V. R., Russell, R. A., Darwish, T., et al. (2021) · ACS Nano · doi:10.1021/acsnano.0c10064 · Cited by 409 · cited 1×
“[98] investigated the structural and compositional effects of apolipoprotein (ApoE) on mRNA-loaded LNPs by evaluating mRNA-loaded LNPs using small-angle neutron scattering and small-angle X-ray scattering, with their findings revealing that ApoE binding to the LNP induced a redistribution of the lipid.”
Qiu, M., Glass, Z., Chen, J., Haas, M., Jin, X., Zhao, X., Rui, X., Ye, Z., Li, Y., Zhang, F., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2020401118 · Cited by 409
On the role of helper lipids in lipid nanoparticle formulations of siRNA
Kulkarni, J. A., Witzigmann, D., Leung, J., Tam, Y. Y. C., & Cullis, P. R. (2019) · Nanoscale · doi:10.1039/c9nr09347h · Cited by 402
Impact of lipid nanoparticle size on mRNA vaccine immunogenicity
Hassett, K. J., Higgins, J., Woods, A., Levy, B., Xia, Y., Hsiao, C. J., Acosta, E., Almarsson, Ö., Moore, M. J., & Brito, L. A. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.05.021 · Cited by 367
Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA
Chen, S., Tam, Y. Y. C., Lin, P. J. C., Sung, M. M. H., Tam, Y. K., & Cullis, P. R. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.059 · Cited by 366
Microfluidic Mixing: A General Method for Encapsulating Macromolecules in Lipid Nanoparticle Systems
Leung, A. K. K., Tam, Y. Y. C., Chen, S., Hafez, I. M., & Cullis, P. R. (2015) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.5b02891 · Cited by 359
COVID-19 Vaccine Frontrunners and Their Nanotechnology Design
Chung, Y. H., Beiss, V., Fiering, S. N., & Steinmetz, N. F. (2020) · ACS Nano · doi:10.1021/acsnano.0c07197 · Cited by 346
Zhigaltsev, I. V., Belliveau, N., Hafez, I., Leung, A. K. K., Huft, J., Hansen, C., & Cullis, P. R. (2012) · Langmuir · doi:10.1021/la204833h · Cited by 345
Miniaturized Battery‐Free Wireless Systems for Wearable Pulse Oximetry
Kim, J., Gutruf, P., Chiarelli, A. M., Heo, S. Y., Cho, K., Xie, Z., Banks, A., Han, S., Jang, K., Lee, J. W., et al. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201604373 · Cited by 334
Manufacturing Considerations for the Development of Lipid Nanoparticles Using Microfluidics
Roces, C. B., Lou, G., Jain, N., Abraham, S., Thomas, A., Halbert, G. W., & Perrie, Y. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12111095 · Cited by 321
Maeki, M., Kimura, N., Sato, Y., Harashima, H., & Tokeshi, M. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.03.008 · Cited by 319
Self-citationScalable mRNA and siRNA Lipid Nanoparticle Production Using a Parallelized Microfluidic Device
Shepherd, S. J., Warzecha, C. C., Yadavali, S., El-Mayta, R., Alameh, M.-G., Wang, L., Weissman, D., Wilson, J. M., Issadore, D., & Mitchell, M. J. (2021) · Nano Letters · doi:10.1021/acs.nanolett.1c01353 · Cited by 317
Systemic delivery of factor IX messenger RNA for protein replacement therapy
Ramaswamy, S., Tonnu, N., Tachikawa, K., Limphong, P., Vega, J. B., Karmali, P. P., Chivukula, P., & Verma, I. M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1619653114 · Cited by 301
A non-viral CRISPR/Cas9 delivery system for therapeutically targeting HBV DNA and pcsk9 in vivo
Jiang, C., Mei, M., Li, B., Zhu, X., Zu, W., Tian, Y., Wang, Q., Guo, Y., Dong, Y., & Tan, X. (2017) · Cell Research · doi:10.1038/cr.2017.16 · Cited by 295
Fenton, O. S., Kauffman, K. J., Kaczmarek, J. C., McClellan, R. L., Jhunjhunwala, S., Tibbitt, M. W., Zeng, M. D., Appel, E. A., Dorkin, J. R., Mir, F. F., et al. (2017) · Advanced Materials · doi:10.1002/adma.201606944 · Cited by 288
Systemic Messenger RNA Therapy as a Treatment for Methylmalonic Acidemia
An, D., Schneller, J. L., Frassetto, A., Liang, S., Zhu, X., Park, J.-S., Theisen, M., Hong, S.-J., Zhou, J., Rajendran, R., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.081 · Cited by 263
An Orthogonal Array Optimization of Lipid-like Nanoparticles for mRNA Delivery in Vivo
Li, B., Luo, X., Deng, B., Wang, J., McComb, D. W., Shi, Y., Gaensler, K. M. L., Tan, X., Dunn, A. L., Kerlin, B. A., et al. (2015) · Nano Letters · doi:10.1021/acs.nanolett.5b03528 · Cited by 261
Polysarcosine-functionalized lipid nanoparticles for therapeutic mRNA delivery
Nogueira, S. S., Schlegel, A., Maxeiner, K., Weber, B., Barz, M., Schroer, M. A., Blanchet, C. E., Svergun, D. I., Ramishetti, S., Peer, D., et al. (2020) · ACS Applied Nano Materials · doi:10.1021/acsanm.0c01834 · Cited by 252
Kimura, N., Maeki, M., Sato, Y., Note, Y., Ishida, A., Tani, H., Harashima, H., & Tokeshi, M. (2018) · ACS Omega · doi:10.1021/acsomega.8b00341 · Cited by 227
Self-citationIonizable lipid nanoparticles for in utero mRNA delivery
Riley, R. S., Kashyap, M. V., Billingsley, M. M., White, B., Alameh, M.-G., Bose, S. K., Zoltick, P. W., Li, H., Zhang, R., Cheng, A. Y., et al. (2021) · Science Advances · doi:10.1126/sciadv.aba1028 · Cited by 222
Kumar, V., Qin, J., Jiang, Y., Duncan, R. G., Brigham, B., Fishman, S., Nair, J. K., Akinc, A., Barros, S. A., & Kasperkovitz, P. V. (2014) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2014.61 · Cited by 222
Systemic Gene Silencing in Primary T Lymphocytes Using Targeted Lipid Nanoparticles
Ramishetti, S., Kedmi, R., Goldsmith, M., Leonard, F., Sprague, A. G., Godin, B., Gozin, M., Cullis, P. R., Dykxhoorn, D. M., & Peer, D. (2015) · ACS Nano · doi:10.1021/acsnano.5b02796 · Cited by 210
Abrams, M. T., Koser, M. L., Seitzer, J., Williams, S. C., DiPietro, M. A., Wang, W., Shaw, A. W., Mao, X., Jadhav, V., Davide, J. P., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2009.208 · Cited by 209
Webb, C., Forbes, N., Roces, C. B., Anderluzzi, G., Lou, G., Abraham, S., Ingalls, L., Marshall, K., Leaver, T. J., Watts, J. A., et al. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119266 · Cited by 201
Maeki, M., Fujishima, Y., Sato, Y., Yasui, T., Kaji, N., Ishida, A., Tani, H., Baba, Y., Harashima, H., & Tokeshi, M. (2017) · PLOS ONE · doi:10.1371/journal.pone.0187962 · Cited by 194
Self-citationKauffman, K. J., Mir, F. F., Jhunjhunwala, S., Kaczmarek, J. C., Hurtado, J. E., Yang, J. H., Webber, M. J., Kowalski, P. S., Heartlein, M. W., DeRosa, F., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.09.006 · Cited by 190
Systemic messenger RNA as an etiological treatment for acute intermittent porphyria
Jiang, L., Berraondo, P., Jericó, D., Guey, L. T., Sampedro, A., Frassetto, A., Benenato, K. E., Burke, K., Santamaría, E., Alegre, M., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0199-z · Cited by 181
Joshi, S., Hussain, M. T., Roces, C. B., Anderluzzi, G., Kastner, E., Salmaso, S., Kirby, D. J., & Perrie, Y. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.09.027 · Cited by 178
Core–Shell Chitosan Microcapsules for Programmed Sequential Drug Release
Yang, X.-L., Ju, X.-J., Mu, X.-T., Wang, W., Xie, R., Liu, Z., & Chu, L.-Y. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b01277 · Cited by 163
Chen, S., Tam, Y. Y. C., Lin, P. J. C., Leung, A. K. K., Tam, Y. K., & Cullis, P. R. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.09.025 · Cited by 160
Hood, R. R., & DeVoe, D. L. (2015) · Small · doi:10.1002/smll.201501345 · Cited by 160
Core/Shell Nanocomposites Produced by Superfast Sequential Microfluidic Nanoprecipitation
Liu, D., Zhang, H., Cito, S., Fan, J., Mäkilä, E. M., Salonen, J., Hirvonen, J. J., Sikanen, T. M., Weitz, D. A., & Santos, H. A. (2017) · Nano Letters · doi:10.1021/acs.nanolett.6b03251 · Cited by 156
Recent Progress in Microfluidics-Based Biosensing
Song, Y., Lin, B., Tian, T., Xu, X., Wang, W., Ruan, Q., Guo, J., Zhu, Z., & Yang, C. J. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b05007 · Cited by 151
Kowalski, P. S., Palmiero, U. C., Huang, Y., Rudra, A., Langer, R., & Anderson, D. G. (2018) · Advanced Materials · doi:10.1002/adma.201801151 · Cited by 145
Preparation of cetyl palmitate-based PEGylated solid lipid nanoparticles by microfluidic technique
Arduino, I., Liu, Z., Rahikkala, A., Figueiredo, P., Correia, A., Cutrignelli, A., Denora, N., & Santos, H. A. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.12.024 · Cited by 128
Terada, T., Kulkarni, J. A., Huynh, A., Chen, S., van der Meel, R., Tam, Y. Y. C., & Cullis, P. R. (2021) · Langmuir · doi:10.1021/acs.langmuir.0c03039 · Cited by 128
Tanaka, H., Takahashi, T., Konishi, M., Takata, N., Gomi, M., Shirane, D., Miyama, R., Hagiwara, S., Yamasaki, Y., Sakurai, Y., et al. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201910575 · Cited by 126
Younis, M. A., Khalil, I. A., Elewa, Y. H. A., Kon, Y., & Harashima, H. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.01.021 · Cited by 126
A strategy for synthesis of lipid nanoparticles using microfluidic devices with a mixer structure
Maeki, M., Saito, T., Sato, Y., Yasui, T., Kaji, N., Ishida, A., Tani, H., Baba, Y., Harashima, H., & Tokeshi, M. (2015) · RSC Advances · doi:10.1039/c5ra04690d · Cited by 123
Self-citationKimura, N., Maeki, M., Sato, Y., Ishida, A., Tani, H., Harashima, H., & Tokeshi, M. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c05489 · Cited by 109
Self-citationSato, Y., Note, Y., Maeki, M., Kaji, N., Baba, Y., Tokeshi, M., & Harashima, H. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.03.019 · Cited by 108
Self-citationBiodegradable Amino-Ester Nanomaterials for Cas9 mRNA Delivery in Vitro and in Vivo
Zhang, X., Li, B., Luo, X., Zhao, W., Jiang, J., Zhang, C., Gao, M., Chen, X., & Dong, Y. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b08163 · Cited by 107
Elia, U., Ramishetti, S., Rosenfeld, R., Dammes, N., Bar‐Haim, E., Naidu, G. S., Makdasi, E., Yahalom-Ronen, Y., Tamir, H., Paran, N., et al. (2021) · ACS Nano · doi:10.1021/acsnano.0c10180 · Cited by 103
Hood, R. R., DeVoe, D. L., Atencia, J., Vreeland, W. N., & Omiatek, D. M. (2014) · Lab on a Chip · doi:10.1039/c4lc00334a · Cited by 102
Suzuki, Y., Onuma, H., Sato, R., Sato, Y., Hashiba, A., Maeki, M., Tokeshi, M., Kayesh, M. E. H., Kohara, M., Tsukiyama–Kohara, K., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.12.013 · Cited by 102
Self-citationProgress of crystallization in microfluidic devices
Shi, H., Xiao, Y., Ferguson, S., Huang, X., Wang, N., & Hao, H. (2017) · Lab on a Chip · doi:10.1039/c6lc01225f · Cited by 98
Spontaneous, solvent-free entrapment of siRNA within lipid nanoparticles
Kulkarni, J. A., Thomson, S. B., Zaifman, J., Leung, J., Wagner, P. K., Hill, A. M., Tam, Y. Y. C., Cullis, P. R., Petkau, T. L., & Leavitt, B. R. (2020) · Nanoscale · doi:10.1039/d0nr06816k · Cited by 80
Formulation and manufacturing of lymphatic targeting liposomes using microfluidics
Khadke, S., Roces, C. B., Cameron, A., Devitt, A., & Perrie, Y. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.06.002 · Cited by 74
Lipid nanoparticles for mRNA delivery
Tanaka, H., Sakurai, Y., & Akita, H. (2022) · Drug Delivery System · doi:10.2745/dds.37.237 · Cited by 74
Hashiba, A., Toyooka, M., Sato, Y., Maeki, M., Tokeshi, M., & Harashima, H. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.08.031 · Cited by 69
Self-citationJia, Z., Gong, Y. Q., Pi, Y., Liu, X., Gao, L., Kang, L., Wang, J., Yang, F., Tang, J., Lu, W., et al. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00709 · Cited by 68
Global efforts on vaccines for COVID-19: Since, sooner or later, we all will catch the coronavirus
Mukherjee, R. (2020) · Journal of Biosciences · doi:10.1007/s12038-020-00040-7 · Cited by 62
Lee, J. B., Zhang, K., Tam, Y. Y. C., Quick, J., Tam, Y. K., Lin, P. J. C., Chen, S., Liu, Y., Nair, J. K., Zlatev, I., et al. (2016) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2016.43 · Cited by 61
Kopp, M. R. G., Linsenmeier, M., Hettich, B., Prantl, S., Stavrakis, S., Leroux, J., & Arosio, P. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.9b05329 · Cited by 57
Basha, G., Ordobadi, M., Scott, W. R., Cottle, A. G., Liu, Y., Wang, H., & Cullis, P. R. (2016) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2016.68 · Cited by 55
Wei, W., Sun, J., Guo, X., Chen, X., Wang, R., Qiu, C., Zhang, H., Pang, W.-H., Wang, J., & Zhang, Q. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b22781 · Cited by 51
Electrohydrodynamic-Driven Micromixing for the Synthesis of Highly Monodisperse Nanoscale Liposomes
Modarres, P., & Tabrizian, M. (2020) · ACS Applied Nano Materials · doi:10.1021/acsanm.9b02407 · Cited by 45
López, R. R., de Rubinat, P. G. F., Sánchez, L.-M., Tsering, T., Alazzam, A., Bergeron, K., Mounier, C., Burnier, J. V., Stiharu, I. G., & Nerguizian, V. (2020) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2020.111447 · Cited by 44
A Versatile, Low-Cost, Multiway Microfluidic Sorter for Droplets, Cells, and Embryos
Utharala, R., Tseng, Q., Furlong, E. E. M., & Merten, C. A. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.7b04689 · Cited by 38
Single-cell RT-LAMP mRNA detection by integrated droplet sorting and merging
Chung, M. T., Kurabayashi, K., & Cai, D. (2019) · Lab on a Chip · doi:10.1039/c9lc00161a · Cited by 38
Three-dimensional, symmetrically assembled microfluidic device for lipid nanoparticle production
Kimura, N., Maeki, M., Sasaki, K., Sato, Y., Ishida, A., Tani, H., Harashima, H., & Tokeshi, M. (2021) · RSC Advances · doi:10.1039/d0ra08826a · Cited by 38
Self-citation3D micromixer for nanoliposome synthesis: a promising advance in high mass productivity
Firmino, P. C. O. D. S., Vianna, S. S. V., da Costa, O. M. M. M., Malfatti-Gasperini, A. A., Gobbi, Â. L., Lima, R. S., & de la Torre, L. G. (2021) · Lab on a Chip · doi:10.1039/d1lc00232e · Cited by 36
Maeki, M., Itô, S., Takeda, R., Ueno, G., Ishida, A., Tani, H., Yamamoto, M., & Tokeshi, M. (2020) · Chemical Science · doi:10.1039/d0sc02117b · Cited by 35
Self-citationKimura, N., Maeki, M., Ishida, A., Tani, H., & Tokeshi, M. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c01519 · Cited by 32
Self-citationDual-functional lipid-like nanoparticles for delivery of mRNA and MRI contrast agents
Luo, X. L., Li, B., Zhang, X., Zhao, W., Bratasz, A., Deng, B., McComb, D. W., & Dong, Y. (2016) · Nanoscale · doi:10.1039/c6nr08496f · Cited by 31
Zhou, K., Johnson, L. T., Xiong, H., Barrios, S., Minnig, J. T., Yan, Y., Abram, B., Yu, X., & Siegwart, D. J. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b01288 · Cited by 23
Li, Y., Boetker, J. P., Rantanen, J., Yang, M., & Bohr, A. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119388 · Cited by 22
Resveratrol Enhances mRNA and siRNA Lipid Nanoparticles Primary CLL Cell Transfection
Kon, E., Hazan‐Halevy, I., Rosenblum, D., Cohen, N., Chatterjee, S., Veiga, N., Raanani, P., Bairey, O., Benjamini, O., Nagler, A., et al. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12060520 · Cited by 21
López, R., Ocampo, I., de Rubinat, P. G. F., Sánchez, L.-M., Alazzam, A., Tsering, T., Bergeron, K., Camacho-León, S., Burnier, J., Mounier, C., et al. (2021) · Langmuir · doi:10.1021/acs.langmuir.1c01005 · Cited by 19
Bolze, H., Riewe, J., Bunjes, H., Dietzel, A. H., & Burg, T. P. (2021) · Chemical Engineering & Technology · doi:10.1002/ceat.202100149 · Cited by 19
Eş, İ., Ok, M. T., Puentes-Martinez, X. E., Toledo, M. A. S., Favaro, M. T. D. P., Cavalcanti, L. P., Cassago, A., Portugal, R. V., Azzoni, A. R., & de la Torre, L. G. (2018) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2018.06.073 · Cited by 15
Li, X., Feng, Q., Han, Z., & Jiang, X. (2021) · Chinese Journal of Chemical Engineering · doi:10.1016/j.cjche.2021.02.009 · Cited by 14
Cited by
Mehta, M., Bui, T. A., Yang, X., Aksoy, Y., Goldys, E. M., & Deng, W. (2023) · ACS Materials Au · doi:10.1021/acsmaterialsau.3c00032 · Cited by 688
Xu, X., Cui, L., Zhang, Y., & Gu, J. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.11.023 · Cited by 13
“Microfluidic mixing, currently the predominant method for mRNA-LNP preparation, ensures superior reproducibility and robust process control 40,41 .”
Metadata
- Authors
- Maeki, M., Uno, S., Niwa, A., Okada, Y., & Tokeshi, M.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2022-04
- Volume
- 344
- Pages
- 80-96
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W4213090198
- Cited by
- 349
- References
- 102
- FWCI
- 18.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.